抗心衰Ⅱ号口服液对实验性心力衰竭和心源性休克的影响  

Effect of "Anti-heart-failure E Oral Liquid" on Experimental Models of Heart-failure and Cardiogenic shock in Anesthetized cat

作　　者：杨玉梅[1] 徐继辉[1] 覃建民[1] 许翠英[1] 李增唏[1] 

机构地区：[1]包头医学院心血管研究室,014010

出　　处：《中草药》1999年第8期599-601,共3页Chinese Traditional and Herbal Drugs

摘　　要：采用麻醉猫实验性心力衰竭和心源性休克的模型观察了抗心衰Ⅱ号口服液（ＡＣⅡ）的作 用。结果表明，ＡＣⅡ可使ＬＶＳＰ、ｄｐ／ｄｔ_（ｍａｘ）、ＣＯ及ＭＡＰ明显增加，ＬＶＥＤＰ明显降低。提示ＡＣⅡ可 增强麻醉猫衰竭心脏的心肌收缩力和心脏泵血功能，具有明显改善心功能的作用。The effect of 'anti-heart-failure Ⅱ oral liquid' (AC Ⅱ) on experimental models of heart failure and cardiogenic shock in anesthetized cat was studied. The results showed that LVSP, dp/dt_(max), CO, MAP were markedly increased and LVEDP was decreased by ACⅡ, suggesting that ACⅡ can improve heart function, and increase cardiac contraction and cardiac output of cat with heart-failure and cardiogenic shock.

关 键 词：抗心衰Ⅱ号 口服液 心力衰竭 心源性休克 治疗 

分 类 号：R259.416[医药卫生—中西医结合] R286.2[医药卫生—中医内科学]